<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39387931</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>10</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1433-7339</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>11</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>10</Day></PubDate></JournalIssue><Title>Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer</Title><ISOAbbreviation>Support Care Cancer</ISOAbbreviation></Journal><ArticleTitle>Healthcare use among cancer survivors during the COVID-19 pandemic: results from the SHARE COVID-19 Survey.</ArticleTitle><Pagination><StartPage>718</StartPage><MedlinePgn>718</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">718</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00520-024-08885-6</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To estimate the association between a previous cancer diagnosis and healthcare use during the COVID-19 pandemic among Europeans and Israelis individuals.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This cross-sectional study was based on data from the Survey of Health, Ageing and Retirement in Europe (SHARE), including the SHARE COVID-19 Survey, which was conducted in the summer of 2020, in 27 countries. Cancer survivors (CS, n = 6409) were country-, sex-, age-, and education-matched (1:2) to non-cancer individuals (NC). Adjusted odds ratios (OR) and 95% confidence intervals (95%CI) were computed using logistic regression.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Overall, CS were more likely to refer that they forwent medical appointments due to fear of COVID-19 (OR = 1.29, 95%CI 1.19-1.41) than NC, particularly those who lived with their partner and other relatives (OR = 1.79, 95%CI 1.39-2.30). Likewise, CS had their medical appointments postponed more often (OR = 1.54, 95%CI 1.44-1.64); this association was stronger among CS who lived with their partner and other relatives (OR = 1.96, 95%CI 1.63-2.36) who reported higher economic difficulties (OR = 1.73, 95%CI 1.50-2.00) and those with no multimorbidity (OR = 1.85, 95%CI 1.62-2.11). CS were also more likely to refer that they were unable to book an appointment (OR = 1.43, 95%CI 1.26-1.63), particularly those who reported that a person close to them died due to COVID-19 (OR = 2.72, 95%CI 1.47-5.01).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">CS were more likely to forgo medical treatment, report healthcare postponements, and be unable to book an appointment than NC, which highlights the importance of closely monitoring the long-term impact of the COVID-19 pandemic along the cancer care continuum.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pimentel</LastName><ForeName>Ana Sofia</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>PortoEPIUnit - Instituto de Saúde Pública Universidade do Porto, Rua das Taipas N.º 135, 4050-600, Porto, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratório para a Investigação Integrativa e Translacional em Saúde Populacional (ITR), Rua das Taipas N.º 135, 4050-600, Porto, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Costa</LastName><ForeName>Ana Rute</ForeName><Initials>AR</Initials><Identifier Source="ORCID">0000-0002-8388-2226</Identifier><AffiliationInfo><Affiliation>PortoEPIUnit - Instituto de Saúde Pública Universidade do Porto, Rua das Taipas N.º 135, 4050-600, Porto, Portugal. arcosta@ispup.up.pt.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratório para a Investigação Integrativa e Translacional em Saúde Populacional (ITR), Rua das Taipas N.º 135, 4050-600, Porto, Portugal. arcosta@ispup.up.pt.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departamento de Ciências da Saúde Pública e Forenses, e Educação Médica, Faculdade de Medicina da Universidade do Porto, Porto, Portugal. arcosta@ispup.up.pt.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2022.03483.CEECIND/CP1732/CT0002</GrantID><Agency>Fundação para a Ciência e a Tecnologia</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Support Care Cancer</MedlineTA><NlmUniqueID>9302957</NlmUniqueID><ISSNLinking>0941-4355</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073116" MajorTopicYN="Y">Cancer Survivors</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005060" MajorTopicYN="N" Type="Geographic">Europe</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007557" MajorTopicYN="N" Type="Geographic">Israel</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010342" MajorTopicYN="N">Patient Acceptance of Health Care</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Cancer survivors</Keyword><Keyword MajorTopicYN="N">Healthcare surveys</Keyword><Keyword MajorTopicYN="N">Neoplasms</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>11</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>11</Day><Hour>10</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>11</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39387931</ArticleId><ArticleId IdType="pmc">PMC11467033</ArticleId><ArticleId IdType="doi">10.1007/s00520-024-08885-6</ArticleId><ArticleId IdType="pii">10.1007/s00520-024-08885-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wu YC, Chen CS, Chan YJ (2020) The outbreak of COVID-19: an overview. J Chin Med : JCMA 83(3):217–220</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7153464</ArticleId><ArticleId IdType="pubmed">32134861</ArticleId></ArticleIdList></Reference><Reference><Citation>Sohrabi C, Alsafi Z, O’Neill N, Khan M, Kerwan A, Al-Jabir A et al (2020) World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19). Int J Surg (London, England) 76:71–76</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7105032</ArticleId><ArticleId IdType="pubmed">32112977</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (2021) Coronavirus (COVID-19) dashboard - global situation. https://covid19.who.int/. Accessed 31 May 2024</Citation></Reference><Reference><Citation>Moynihan R, Sanders S, Michaleff ZA, Scott AM, Clark J, To EJ et al (2021) Impact of COVID-19 pandemic on utilisation of healthcare services: a systematic review. BMJ Open 11(3):e045343</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7969768</ArticleId><ArticleId IdType="pubmed">33727273</ArticleId></ArticleIdList></Reference><Reference><Citation>Peiffer-Smadja N, Lucet JC, Bendjelloul G, Bouadma L, Gerard S, Choquet C et al (2020) Challenges and issues about organizing a hospital to respond to the COVID-19 outbreak: experience from a French reference centre. Clin Microbiol Infect 26(6):669–672</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7141639</ArticleId><ArticleId IdType="pubmed">32278082</ArticleId></ArticleIdList></Reference><Reference><Citation>Bokolo AJ (2020) Use of telemedicine and virtual care for remote treatment in response to COVID-19 pandemic. J Med Syst 44(7):132</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7294764</ArticleId><ArticleId IdType="pubmed">32542571</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (2020) COVID-19 significantly impacts health services for noncommunicable diseases. http://who.int/news/item/01-06-2020-significantly-impacts-health-services-for-noncommunicable-diseases. Accessed 20 Aug 2021</Citation></Reference><Reference><Citation>Richards M, Anderson M, Carter P, Ebert BL, Mossialos E (2020) The impact of the COVID-19 pandemic on cancer care. Nature Cancer 1(6):565–567</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7238956</ArticleId><ArticleId IdType="pubmed">35121972</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson BA, Waddimba AC, Ogola GO, Fleshman JW Jr, Preskitt JT (2021) A systematic review and meta-analysis of surgery delays and survival in breast, lung and colon cancers: implication for surgical triage during the COVID-19 pandemic. Am J Surg 222(2):311–318</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7834494</ArticleId><ArticleId IdType="pubmed">33317814</ArticleId></ArticleIdList></Reference><Reference><Citation>Morais S, Antunes L, Rodrigues J, Fontes F, Bento MJ, Lunet N (2021) The impact of the COVID-19 pandemic on the short-term survival of patients with cancer in Northern Portugal. Int J Cancer 149(2):287–296</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8014057</ArticleId><ArticleId IdType="pubmed">33634852</ArticleId></ArticleIdList></Reference><Reference><Citation>Maringe C, Spicer J, Morris M, Purushotham A, Nolte E, Sullivan R et al (2020) The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study. Lancet Oncol 21(8):1023–1034</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7417808</ArticleId><ArticleId IdType="pubmed">32702310</ArticleId></ArticleIdList></Reference><Reference><Citation>Blay JY, Boucher S, Le Vu B, Cropet C, Chabaud S, Perol D et al (2021) Delayed care for patients with newly diagnosed cancer due to COVID-19 and estimated impact on cancer mortality in France. ESMO open 6(3):100134</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8134718</ArticleId><ArticleId IdType="pubmed">33984676</ArticleId></ArticleIdList></Reference><Reference><Citation>Börsch-Supan A, Brandt M, Hunkler C, Kneip T, Korbmacher J, Malter F et al (2013) Data resource profile: the survey of health, ageing and retirement in Europe (SHARE). Int J Epidemiol 42(4):992–1001</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3780997</ArticleId><ArticleId IdType="pubmed">23778574</ArticleId></ArticleIdList></Reference><Reference><Citation>Borsch-Supan A (2020) Survey of Health, Ageing and Retirement in Europe (SHARE) wave 8. COVID-19 Survey 1. Release version: 0.0.1. beta. SHARE-ERIC. 10.6103/SHARE.w1.800</Citation></Reference><Reference><Citation>SHARE-ERIC (2020) SHARE COVID-19 survey - release guide 2020 December 17. https://share-eric.eu/data/data-setdetails/share-corona-survey-1</Citation></Reference><Reference><Citation>Annette S, Kathrin A, Michael B, Salima D, Andrea O, Gregor S, et al (2020) Collecting survey data among the 50+ population during the COVID-19 outbreak: the Survey of Health, Ageing and Retirement in Europe (SHARE). Survey Res Methods 14(2). 10.18148/srm/2020.v14i2.7738</Citation></Reference><Reference><Citation>Costa AR, Alves L, Lunet N (2020) Healthcare services and medication use among cancer survivors and their partners: a cross-sectional analysis of 16 European countries. J Cancer Surviv 14(5):720–730</Citation><ArticleIdList><ArticleId IdType="pubmed">32594450</ArticleId></ArticleIdList></Reference><Reference><Citation>Treanor C, Donnelly M (2012) An international review of the patterns and determinants of health service utilisation by adult cancer survivors. BMC Health Serv Res 12:316</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3465193</ArticleId><ArticleId IdType="pubmed">22973899</ArticleId></ArticleIdList></Reference><Reference><Citation>Nekhlyudov L, Mollica MA, Jacobsen PB, Mayer DK, Shulman LN, Geiger AM (2019) Developing a quality of cancer survivorship care framework: implications for clinical care, research, and policy. J Natl Cancer Inst 111(11):1120–1130</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6855988</ArticleId><ArticleId IdType="pubmed">31095326</ArticleId></ArticleIdList></Reference><Reference><Citation>Santin O, Mills M, Treanor C, Donnelly M (2012) A comparative analysis of the health and well-being of cancer survivors to the general population. Support Care Cancer 20(10):2545–2552</Citation><ArticleIdList><ArticleId IdType="pubmed">22262132</ArticleId></ArticleIdList></Reference><Reference><Citation>Travis LB (2006) The epidemiology of second primary cancers. Cancer Epidemiol, Biomarkers Prev : a Publ Am Assoc Cancer Res, Cosponsored Am Soc Preventive Oncol 15(11):2020–2026</Citation><ArticleIdList><ArticleId IdType="pubmed">17057028</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacheco-Figueiredo L, Lunet N (2014) Health status, use of healthcare, and socio-economic implications of cancer survivorship in Portugal: results from the fourth national health survey. J Cancer Survivorship : Res Prac 8(4):611–617</Citation><ArticleIdList><ArticleId IdType="pubmed">24903019</ArticleId></ArticleIdList></Reference><Reference><Citation>Jazieh AR, Akbulut H, Curigliano G, Rogado A, Alsharm AA, Razis ED, et al (2020) Impact of the COVID-19 pandemic on cancer care: a global collaborative study (6):1428–38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7529504</ArticleId><ArticleId IdType="pubmed">32986516</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhada S, Stewart D, Cheema E, Hadi MA, Paudyal V (2021) Cancer services during the COVID-19 pandemic: systematic review of patient’s and caregiver’s experiences. Cancer Manag Res 13:5875–5887</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8328387</ArticleId><ArticleId IdType="pubmed">34349561</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang W, Guan W, Chen R, Wang W, Li J, Xu K et al (2020) Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 21(3):335–337</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159000</ArticleId><ArticleId IdType="pubmed">32066541</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Shamsi HO, Alhazzani W, Alhuraiji A, Coomes EA, Chemaly RF, Almuhanna M et al (2020) A practical approach to the management of cancer patients during the novel coronavirus disease 2019 (COVID-19) pandemic: an International Collaborative Group. Oncologist 25(6):e936–e945</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7288661</ArticleId><ArticleId IdType="pubmed">32243668</ArticleId></ArticleIdList></Reference><Reference><Citation>Meggetto O, Jembere N, Gao J, Walker M, Rey M, Rabeneck L, et al (2021) The impact of the COVID-19 pandemic on the Ontario Cervical Screening Program, colposcopy and treatment services in Ontario, Canada: a population-based study 128(9):1503–10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8209864</ArticleId><ArticleId IdType="pubmed">33982870</ArticleId></ArticleIdList></Reference><Reference><Citation>Bardet A, Fraslin AM, Marghadi J, Borget I, Faron M, Honoré C, et al (2021) Impact of COVID-19 on healthcare organisation and cancer outcomes. European journal of cancer (Oxford, England : 1990) 153:123–32</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8213441</ArticleId><ArticleId IdType="pubmed">34153714</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasion R, Paiva TO, Fernandes C, Barbosa F. The AGE effect on protective behaviors during the COVID-19 outbreak: sociodemographic, perceptions and psychological accounts. 2020;11(2785).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7595956</ArticleId><ArticleId IdType="pubmed">33178069</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang W, Guan W, Chen R, Wang W, Li J, Xu K et al (2020) Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 21(3):335–337</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159000</ArticleId><ArticleId IdType="pubmed">32066541</ArticleId></ArticleIdList></Reference><Reference><Citation>Kent EE, Forsythe LP, Yabroff KR, Weaver KE, de Moor JS, Rodriguez JL et al (2013) Are survivors who report cancer-related financial problems more likely to forgo or delay medical care? Cancer 119(20):3710–3717</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4552354</ArticleId><ArticleId IdType="pubmed">23907958</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritter PL, Stewart AL, Kaymaz H, Sobel DS, Block DA, Lorig KR (2001) Self-reports of health care utilization compared to provider records. J Clin Epidemiol 54(2):136–141</Citation><ArticleIdList><ArticleId IdType="pubmed">11166528</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman R (2015) Comparison of telephone and in-person interviews for data collection in qualitative human research. Interdiscip Undergrad Res J 1(1):10–13</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>